Related Experiment Videos

How to improve neuroprotection in Parkinson's disease?

E C Hirsch1

  • 1INSERM U679, Experimental Neurology and Therapeutics, Hôpital de la Salpêtrière, Paris, France. hirsch@crr.jussieu.fr

Parkinsonism & Related Disorders
|November 19, 2008
PubMed

Insights

Parkinson's disease (PD) may stem from genetic and environmental factors, potentially requiring combination therapies. Glial cell-released toxins might perpetuate neurodegeneration, offering a new therapeutic target.

Area of Science:

  • Neuroscience
  • Pathology
  • Pharmacology

Background:

  • Parkinson's disease (PD) etiology is multifactorial, involving genetic and environmental influences.
  • Multiple cellular insults are implicated in the neurodegenerative process of PD.
  • PD progression may continue independently of the initial trigger.

Purpose of the Study:

  • To explore the complex etiology of Parkinson's disease.
  • To identify potential therapeutic strategies for PD.
  • To investigate the role of glial cells in PD pathogenesis.

Main Methods:

  • Review of current literature on PD etiology.
  • Analysis of proposed cellular mechanisms in neurodegeneration.
  • Discussion of potential therapeutic interventions.

Main Results:

  • Evidence suggests a combination of genetic and environmental factors contribute to PD.
  • Multiple cellular hits likely drive neurodegeneration in PD.
  • Glial cell-derived toxic substances may perpetuate neuronal damage in PD.

Conclusions:

  • Therapeutic strategies for PD may necessitate targeting multiple pathways simultaneously.
  • Glial cell activity represents a potential therapeutic target for halting PD progression.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...